AxoProtego Therapeutics (Axo) has announced that Daniel M Jorgensen, MD, MPH, MBA, has joined as CEO. Dr. Jorgensen is an accomplished physician executive with 22+ years of industry experience in roles of increasing responsibility, in small and large companies. His background includes comprehensive research, development, an
August 3, 2020
· 3 min read